Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
Ying Yang, Yongfeng Yu, Shun Lü
Topics & Concepts
DurvalumabPembrolizumabNivolumabAtezolizumabMedicineAvelumabLung cancerOncologyClinical trialPD-L1Internal medicineCancerImmunotherapyIntensive care medicineCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies